Your session is about to expire
← Back to Search
Behavioural Intervention
PRIDE Therapy for Eating Disorders
Phase 1
Waitlist Available
Led By Aaron Blashill, PhD
Research Sponsored by Auburn University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 18 to 65 years
Meet criteria for a Diagnostic and Statistical Manual - 5 (DSM-5) eating disorder (i.e., anorexia nervosa, bulimia nervosa, binge eating disorder, other specified feeding or eating disorder)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline through 3- and 6-month follow-up
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to see if a new treatment called PRIDE can help sexual minority populations with eating disorders by reducing internalized stigma and improving coping with stress. Participants will go through screening processes, attend therapy
Who is the study for?
This trial is for sexual minority individuals diagnosed with eating disorders. Participants must complete a phone screening, a clinical interview to confirm their diagnosis, and self-report measures for eligibility. They cannot have other non-eating disorder diagnoses that could interfere with the study.
What is being tested?
The PRIDE intervention is being tested to see if it can reduce internalized stigma and improve coping with stress related to being a sexual minority. It involves up to 14 weekly therapy sessions focused on addressing eating disorders and body image issues while enhancing resilience against minority stressors.
What are the potential side effects?
Since this trial involves psychological therapy rather than medication, side effects may include emotional discomfort or distress when discussing sensitive topics like stigma and personal challenges related to one's sexual identity.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 65 years old.
Select...
I have been diagnosed with an eating disorder like anorexia, bulimia, or binge eating.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline through 3- and 6-month follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline through 3- and 6-month follow-up
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Coping Self Efficacy Scale (CSES)
Internalized Homophobia Scale (IHP)
Sexual Orientation Implicit Association Test
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: PsychotherapyExperimental Treatment1 Intervention
Participants in this arm will experience the PRIDE intervention. PRIDE is a 14-session treatment that incorporates aspects of cognitive behavioral therapy for eating disorders (CBT-E) and SM-affirmative therapy. CBT-E aspects of treatment include in-session weighing, self-monitoring (food logs), regular eating, and techniques to address overvaluation of weight and shape. SM-affirmative therapy techniques include discussing the impact of minority stress on health, resilience, and strength within the SM community, specific manifestations of minority stress on eating and body image, current coping strategies, emotion regulation skills, and developing mindful, present-focused reactions to minority stress.
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Auburn UniversityLead Sponsor
80 Previous Clinical Trials
14,589 Total Patients Enrolled
San Diego State UniversityOTHER
170 Previous Clinical Trials
115,051 Total Patients Enrolled
Aaron Blashill, PhDPrincipal InvestigatorSan Diego State University
Tiffany Brown, PhDPrincipal InvestigatorAuburn University